Stat consult: Lyme disease

Share this content:
The Lyme disease spirochete, Borrelia burgdorferi, is an obligate parasite.
The Lyme disease spirochete, Borrelia burgdorferi, is an obligate parasite.

Description


  • most common tickborne infection in North America and Europe 



Also called


  • Lyme borreliosis



Types


  • early Lyme disease

    • early localized Lyme disease—single erythema migrans (EM) lesion at site of tick bite
      • round, flat or raised, erythema expanding in diameter over days to weeks

      • may have area of central clearing ("target lesion") 

      • appears about 7 -14 days after tick detaches

      • often in axilla, back, abdomen, groin, and popliteal fossa

      • may also have
        • systemic symptoms (fever, chills, fatigue, arthralgias, or myalgias)

        • regional lymphadenopathy 

    • early disseminated Lyme disease
      • multiple EM lesions

      • early neurologic Lyme disease
        • cranial nerve palsy

        • meningitis

        • acute radiculopathy

        • mononeuropathy multiplex 

      • Lyme carditis - atrioventricular block and/or myopericarditis

    • borrelial lymphocytoma (rare)
      • cutaneous solitary bluish-red swelling < few centimeters in size

      • often due to Borrelia afzelii in Europe

  • late Lyme disease
    • Lyme arthritis
      • monoarticular or oligoarticular

      • affects knee, other large joints or TMJ

    • late neurologic Lyme disease
      • encephalomyelitis

      • encephalopathy

      • peripheral neuropathy

    • acrodermatitis chronica atrophicans


Estimated incidence


  • about 329,000 cases annually in US and 85,000 in Europe 


Associated conditions 


  • co-infection with anaplasmosis or babesiosis 

  • flaviviruses 



Pathogens 


  • Borrelia burgdorferi sensu lato spirochete species complex

  • common species 

    • B. burgdorferi (USA)

    • B. afzelii (Europe)

    • B. garinii (Europe)

    • B. spielmanii and B. bavariensis

Transmission 


  • Ixodes ticks 

    • I. scapularis (previously I. dammini) in northeast and upper midwestern US (primarily transmits B. burgdorferi)

    • I. pacificus in western US (B. burgdorferi )

    • I. ricinus in Europe (B. garinii and B. afzelii )

    • I. persulcatus in Asia (B. garinii and B. afzelii )

  • reservoir hosts

    • I. scapularis
      • white-tailed deer 

      • small mammals, especially white-footed mouse

    • I. ricinus
      • large mammals (cattle, deer)

      • small rodents (wood mice, voles)

  • injection of nymphal tick saliva during feeding

    • I. scapularis and I. pacificus need 36-72 hours feeding to transmit enough spirochetes to cause infection 

    • B. afzelii transmission may be more rapid

  • nymphal tick activity most active late May-September

  • average incubation period 7-10 days


Testing 


  • with EM, empiric diagnosis (compatible history, potential exposure, and exam findings) without testing

  • routine blood tests

    • WBC, hemoglobin, and platelets usually normal unless co-infection with Anaplasma phagocytophilum, Babesia microti, or tick-borne encephalitis virus 

    • LFTs slightly elevated in early disease

    • ESR elevations common, rarely > 80 mm/hour

  • for non-EM presentations, 2-tiered serologic testing recommended 

    • screening immunoassay—if negative, no further testing

    • if positive, supplementary Western blot
      • IgM positive when both
        • ≥ 2 of 3 specific bands present

        • duration of infection < 4 weeks

      • IgG positive when both
        • ≥ 5 of 10 specific bands present

        • duration of infection > 4 weeks

    • if negative in early Lyme disease, consider repeat testing 

  • other testing may include

    • CSF 

    • synovial fluid 

    • skin biopsy (rare)


Page 1 of 2
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs